SYT15
Synaptotagmin-15
Also known as: CHR10SYT, SYT15_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BQS2
- Gene
- SYT15
- Ensembl
- ENSG00000204176
- Chromosome
- 10
- Canonical length
- 421 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Golgi apparatus
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the Synaptotagmin (Syt) family of membrane trafficking proteins. Members of this family contain a transmembrane region and a C-terminal-type tandem C2 domain. Unlike related family members, the encoded protein may be involved in membrane trafficking in non-neuronal tissues. Two trancript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
421 residues, UniProt reviewed canonical sequence.
>Q9BQS2|SYT15
1 MAEQLALVIG GTIGGLLLLL LIGASCCLWR RFCATLTYEE LPGTPAMATT AASSGQRDRP
61 CQPHARTQLS RPPAVPFVVP PTLQGRDWVP LHSGEWADAP WDPCPASELL PHTSSGGLGD
121 ACMVGAINPE LYKFPEDKSE TDFPDGCLGR LWFSVEYEQE AERLLVGLIK AQHLQAPSET
181 CSPLVKLYLL PDERRFLQSK TKRKTSNPQF DEHFIFQVSS KTITQRVLKF SVYHVDRQRK
241 HQLLGQVLFP LKNETLVGDC RRVIWRDLEA ESLEPPSEFG DLQFCLSYND YLSRLTVVVL
301 RAKGLRLQED RGIVSVFVKV SLMNHNKFVK CKKTSAVLGS INPVYNETFS FKADATELDT
361 ASLSLTVVQN MEGDKSQQLG RVVVGPYMYT RGRELEHWDE MLSKPKELVK RWHALCRTTE
421 PLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SYT15 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 7.7 nTPM
Expression across tissuesHPA
Tissue
- lung: 7.7 nTPM
- skin: 5.3 nTPM
- cerebral cortex: 4.5 nTPM
- pancreas: 3.5 nTPM
- lymph node: 3.4 nTPM
- placenta: 3.4 nTPM
Single-cell type
- alveolar cells type 1: 9.8 nCPM
- vascular endothelial cells: 9.1 nCPM
- alveolar cells type 2: 3.4 nCPM
- lymphatic endothelial cells: 2.9 nCPM
- kupffer cells: 2 nCPM
- transitional alveolar cells: 2 nCPM
Immune cell
- intermediate monocyte: 1.2 nTPM
- non-classical monocyte: 1 nTPM
- classical monocyte: 0.5 nTPM
- gdT-cell: 0.5 nTPM
- MAIT T-cell: 0.5 nTPM
- memory CD4 T-cell: 0.5 nTPM
Brain region
- cerebral cortex: 32 nTPM
- hippocampal formation: 29 nTPM
- amygdala: 21 nTPM
- pons: 20 nTPM
- basal ganglia: 20 nTPM
- thalamus: 20 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.78
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.06
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SYT15 as an antibody target. Whether an autoantibody or antibody against SYT15 could matter depends on whether native SYT15 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SYT15 is annotated at the cell surface, where native SYT15 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SYT15 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...